FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Department of Medicine 4 – Nephrology and Hypertension
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Overview
Publications
(1,181)
Research Grants
(11)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Electrocardiographic parameters of left ventricular hypertrophy and prediction of mortality in hemodialysis patients (2021)
Braunisch MC, Gundel P, Werfel S, Mayer CC, Bauer A, Haller B, Guenthner R, et al.
Journal article
Visualization of the epimysium and fascia thoracolumbalis at the lumbar spine using MRI (2021)
Adamietz B, Schoenberg SO, Reiser M, Uder M, Frank A, Strecker R, Weiss C, Heiß R
Journal article
THE SGLT2 INHIBITOR EMPAGLIFLOZIN REDUCES TISSUE SODIUM CONTENT IN PATIENTS WITH CHRONIC HEART FAILURE (2021)
Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, et al.
Conference contribution
EFFECTS OF THE SGLT2 INHIBITOR EMPAGLIFLOZIN ON VASCULAR FUNCTION IN PATIENTS WITH CHRONIC HEART FAILURE (2021)
Kolwelter J, Bosch A, Jung S, Linz P, Kannenkeril D, Nagel AM, Ott C, et al.
Conference contribution
Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease (2021)
Ortiz A, Ferro CJ, Balafa O, Burnier M, Ekart R, Halimi JM, Kreutz R, et al.
Journal article
EFFECTS OF FINERENONE ON CARDIORENAL OUTCOMES IN BLOOD PRESSURE SUBGROUPS IN PATIENTS WITH CKD AND T2D (2021)
Ruilope L, Agarwal R, Anker SD, Filippatos G, Pitt B, Rossing P, Sarafidis P, et al.
Conference contribution
OSTEOPONTIN AND ITS ASSOCIATION WITH ADVERSE EVENTS IN THE GERMAN CHRONIC KIDNEY DISEASE STUDY (2021)
Steinbrenner I, Cheng Y, Nadal J, Schmid M, Kotsis FK, Meiselbach H, Schneider M, et al.
Conference contribution
SELF-REPORTED MEDICATION USE AND URINARY DRUG METABOLITES IN THE GERMAN CHRONIC KIDNEY DISEASE (GCKD) STUDY: A PHARMACOMETABOLOMIC APPROACH (2021)
Kotsis FK, Schultheiss UT, Wuttke M, Schlosser P, Oefner P, Mohney RP, Eckardt KU, et al.
Conference contribution
FIRST RESULTS OF THE COVID-19 PATIENTS TREATED WITH THE SERAPH (R) 100 MICROBIND (R) AFFINITY FILTER (COSA) REGISTRY (2021)
Schmidt JJ, Van'T Klooster M, Borchina DN, Buettner S, Bader B, Herbst L, Fuehner T, Kielstein JT
Conference contribution
CHANGES IN THE KYNURENINE PATHWAY LEAD TO ALTERATIONS IN NAD BALANCE AND BIOENERGETICS PARAMETERS IN GLOMERULAR CELLS IN VITRO AND CONTRIBUTE TO PROTEINURIA IN A ZEBRAFISH MODEL (2021)
Bolanos-Palmieri P, Kotb A, Schenk H, Baehre H, Schroder P, Schiffer M
Conference contribution
‹
1
...
29
30
31
32
33
...
109
›